# Pivot Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pivot-bio

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.pivotbio.com
- Total disclosed funding: $618M
- Latest round: Series D (Jul 19, 2021)
- Investors on record: 16

## About

Founded in 2010 and based in California, US, Pivot Bio operates as a biotechnology company that develops an alternative to synthetic nitrogen fertilizer for farmers. The firm was founded by Alvin Tamsir and Karsten Temme. In July 2021, Pivot Bio, Inc. raised USD 430 million in Series D funding co-led by returning investors Data Collective and Temasek Holdings, with participation from other returning investors, Breakthrough Energy Ventures, Bunge Investment Management, Continental Grain Company, Pavilion Capital, Prelude Ventures, and Tekfen Ventures.
 
Pivot Bio, Inc. provides farmers with solutions that enable them to grow quality, environmentally responsible, and sustainably focused crops. Its products include Pivot Bio PROVEN 40, which is a nitrogen-producing microbe fed to corn plants directly during the growth stage that enables farmers to replace up to 40 pounds per acre of synthetic nitrogen, and Pivot Bio RETURN N, which helps ensure nitrogen is no longer the limiting factor when it comes to wheat or sorghum plants.

## Funding rounds

- Series D, Jul 19, 2021, $430M — Temasek Holdings, Generation Investment Management, Bunge Investment Management, Prelude Ventures, Pavilion Capital, DCVC, Breakthrough Energy Ventures, Tekfen Ventures, G2 Venture Partners, Conti Ventures, Rockefeller Capital Management
- Series C, Jan 6, 2020, $100M — Temasek Holdings, Bunge Investment Management, Prelude Ventures, Pavilion Capital, DCVC, Spruce Capital Partners, Breakthrough Energy Ventures, Tekfen Ventures, Conti Ventures, Codon Capital
- Series B, Oct 2, 2018, $71M — Temasek Holdings, Breakthrough Energy Ventures
- Series A, Mar 22, 2016, $16M — Bill & Melinda Gates Foundation, DCVC, Monsanto Growth Ventures, Awaken Capital
- Seed, Oct 1, 2014, $0.8M — DCVC, Monsanto Growth Ventures

## Investors

- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed, Series A, Series C, Series D
- Monsanto Growth Ventures (https://capitalatlas.ai/funds/monsanto-growth-ventures) — Seed, Series A
- Bill & Melinda Gates Foundation — Series A
- Awaken Capital (https://capitalatlas.ai/funds/awaken-capital) — Series A
- Temasek Holdings — Series B, Series C, Series D
- Breakthrough Energy Ventures (https://capitalatlas.ai/funds/breakthrough-energy-ventures) — Series B, Series C, Series D
- Bunge Investment Management — Series C, Series D
- Prelude Ventures — Series C, Series D
- Pavilion Capital — Series C, Series D
- Spruce Capital Partners (https://capitalatlas.ai/funds/spruce-capital-partners) — Series C
- Tekfen Ventures (https://capitalatlas.ai/funds/tekfen-ventures) — Series C, Series D
- Conti Ventures — Series C, Series D
- Codon Capital (https://capitalatlas.ai/funds/codon-capital) — Series C
- Generation Investment Management (https://capitalatlas.ai/funds/generation-investment-management) — Series D
- G2 Venture Partners (https://capitalatlas.ai/funds/g2-venture-partners) — Series D
- Rockefeller Capital Management — Series D